AI Has High Sensitivity for Abnormal Chest Radiographs
WEDNESDAY, March 8, 2023 (HealthDay News) — An artificial intelligence (AI) tool has very high sensitivity for abnormal chest radiographs, according to a study published online March 7 in Radiology.Louis L. Plesner, M.D., from Herlev and Gentofte Hos…
Learn MoreACC: Treat-to-Target LDL-C Strategy Noninferior to High-Intensity Statins
TUESDAY, March 7, 2023 (HealthDay News) — For patients with coronary artery disease, a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy is noninferior to high-intensity statin therapy, according to a study published online March 6…
Learn MoreACC: Young U.S. Adults Face High, Rising Burden of Cardiovascular Risk Factors
TUESDAY, March 7, 2023 (HealthDay News) — The prevalence of diabetes and obesity increased and the prevalence of hypertension did not decrease among young adults in the United States from 2009 through March 2020, according to a study published online…
Learn MoreCleft Procedures Undervalued Relative to Craniofacial Procedures
TUESDAY, March 7, 2023 (HealthDay News) — The current relative value unit (RVU) system undervalues cleft procedures versus craniofacial procedures performed by plastic surgeons, according to a study published online Feb. 24 in Plastic and Reconstruct…
Learn MoreVaginal Erbium YAG Laser Beneficial for Overactive Bladder Syndrome
TUESDAY, March 7, 2023 (HealthDay News) — Vaginal Erbium YAG laser is beneficial for postmenopausal women with overactive bladder syndrome (OAB) and vaginal atrophy, according to a study published online Feb. 28 in Menopause.Keerati Chiengthong, M.D….
Learn MoreNine Novel Prostate Cancer Variants Identified in Men With African Ancestry
TUESDAY, March 7, 2023 (HealthDay News) — In a study of men of African ancestry, published online March 3 in European Urology, nine novel prostate cancer risk variants have been identified.Fei Chen, Ph.D., from the Keck School of Medicine at the Univ…
Learn MoreClinical Treatment Considerations Presented for Severe Mpox
TUESDAY, March 7, 2023 (HealthDay News) — In a report published in the March 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, interim clinical treatment considerations are presented for severe mani…
Learn MoreMotavizumab, Nirsevimab, Palivizumab Beneficial for RSV Prevention
TUESDAY, March 7, 2023 (HealthDay News) — Significant benefits are seen with motavizumab, nirsevimab, and palivizumab for prevention of respiratory syncytial virus (RSV) in infants and children, according to a review published online Feb. 17 in JAMA …
Learn MoreVerapamil Partially Preserves C-Peptide Secretion in Children With T1DM
TUESDAY, March 7, 2023 (HealthDay News) — Verapamil partially preserves stimulated C-peptide secretion at 52 weeks after diagnosis among children with newly diagnosed type 1 diabetes, according to a study published online Feb. 24 in the Journal of th…
Learn MoreMechanical Thrombectomy Comparable to Best Medical Treatment for Rare Type of Stroke
TUESDAY, March 7, 2023 (HealthDay News) — For patients with primary isolated distal medium vessel occlusions (DMVOs) of the anterior cerebral artery (ACA), mechanical thrombectomy (MT) has comparable clinical and safety outcomes to best medical treat…
Learn More